Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 6/20 | 1.00 |
| ▸ | LMNA | P02545 | 5/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 1.00 |
| ▸ | ATM | Q13315 | 2/20 | 1.00 |
| ▸ | NR3C1 | P04150 | 2/20 | 1.00 |
| ▸ | SHBG | P04278 | 2/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 2/20 | 1.00 |
| ▸ | HTR2B | P41595 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | FYN | P06241 | 1/20 | 1.00 |
| ▸ | ADRA2C | P18825 | 1/20 | 1.00 |
| ▸ | SLC6A2 | P23975 | 1/20 | 1.00 |
| ▸ | HTT | P42858 | 1/20 | 1.00 |
| ▸ | PGR | P06401 | 2/20 | 0.77 |
| ▸ | AR | P10275 | 2/20 | 0.77 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.77 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.77 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.77 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Estradiol Benzoate SCHEMBL22049057 | 1.00 | ESR1 (1.00) | ESR1LMNASMN1; SMN2ADORA3ATM | |
| Estradiol Benzoate SCHEMBL18467889 | 1.00 | ESR1 (1.00) | ESR1LMNASMN1; SMN2ADORA3ATM | |
| Estradiol Benzoate SCHEMBL14360474 | 1.00 | ESR1 (1.00) | ESR1LMNASMN1; SMN2ADORA3ATM | |
| Estradiol Benzoate SCHEMBL12187133 | 1.00 | ESR1 (1.00) | ESR1LMNASMN1; SMN2ADORA3ATM | |
| Estradiol Benzoate SCHEMBL174896 | 1.00 | ESR1 (1.00) | ESR1LMNASMN1; SMN2ADORA3ATM | |
| Estradiol Benzoate SCHEMBL12180364 | 1.00 | ESR1 (1.00) | ESR1LMNASMN1; SMN2ADORA3ATM | |
| Estradiol Benzoate SCHEMBL301616 | 1.00 | ESR1 (1.00) | ESR1LMNASMN1; SMN2ADORA3ATM | |
| Estradiol Benzoate SCHEMBL9320465 | 1.00 | ESR1 (1.00) | ESR1LMNASMN1; SMN2ADORA3ATM | |
| Estradiol Benzoate SCHEMBL20770923 | 0.99 | ESR1 (0.98) | ESR1LMNASMN1; SMN2ADORA3ATM | |
| Estradiol Benzoate SCHEMBL5885955 | 0.96 | ESR1 (0.93) | ESR1LMNASMN1; SMN2ADORA3ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3089732-B1 | CONTROLLED RELEASE FATTY ACID COMPOSITIONS FOR USE IN BODY RECONSTRUCTION AND BODY-SHAPING | PB&B SA (CH) | 2023-09-27 | — | — | EP | claimed |
| EP-3886816-B1 | ESTRADIOL BENZOATE AS A STERILANT | INSIGNA INC (US) | 2023-09-13 | — | — | EP | claimed |
| EP-2040683-B2 | PHARMACEUTICAL COMPOSITION CONTAINING A TETRAHYDROFOLIC ACID | BAYER IP GMBH (DE) | 2023-08-16 | — | — | EP | claimed |
| CN-112423590-B | Mixtures and use comprising benzpyrimoxan and oxazosulfyl and methods for their application | 巴斯夫欧洲公司 | 2022-07-08 | — | — | CN | claimed |
| EP-3616756-B1 | COMPOSITION FOR PROMOTING HAIR GROWTH, USE OF THE HAIR GROWTH AGENT AND METHOD FOR PRODUCING THE SAME | MUELLER KAEHMANN DIETER KLAUS (DE) | 2022-03-09 | — | — | EP | claimed |
| EP-4747409-A2 | COLLECTION, ASSESSMENT AND EARLY DETECTION OF HUMAN LUNG CANCER BIOMARKERS IN EXHALED BREATH CONDENSATES OF MOUSE ANIMAL MODELS | Hackensack Meridian Health, Inc. (US) | 2026-05-27 | — | — | EP | disclosed |
| EP-4673465-A1 | ANTI-NETRIN-1 MONOCLONAL ANTIBODY FOR TREATING ENDOMETRIOSIS AND ASSOCIATED PAINS | South Australian Health and Medical Research Institute Limited (AU) | 2026-01-07 | — | — | EP | disclosed |
| US-12429485-B2 | Biomarker panels for on-treatment prediction of response to immuno-oncology drugs | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2025-09-30 | — | — | US | disclosed |
| US-12383132-B2 | Identification and control of myopic progression using distortion | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2025-08-12 | — | — | US | disclosed |
| US-20250223567-A1 | COMPOSITIONS AND METHODS FOR OBTAINING VASCULARIZED HUMAN INTESTINAL ORGANOID TISSUE, AND RELATED USES THEREOF | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2025-07-10 | — | — | US | disclosed |
| EP-4580644-A1 | ADVANCED ALVEOLAR EPITHELIAL ORGANOIDS | Children's Hospital Medical Center (US) | 2025-07-09 | — | — | EP | disclosed |
| US-20250057873-A1 | Intestinal Tumor Suppressor, PGE2 Production Inhibitor, and IL-22BP Production Promoter | LOUIS PASTEUR CENTER FOR MEDICAL RESEARCH (JP) | 2025-02-20 | — | — | US | disclosed |
| EP-4039589-A1 | HULL SYSTEM AND AIRCRAFT | Airbus Helicopters (FR) | 2022-08-10 | — | — | EP | disclosed |
| WO-2022140386-A1 | DETECTION OF LUNG CANCER USING CELL-FREE DNA FRAGMENTATION | THE JOHNS HOPKINS UNIVERSITY (US) | 2022-06-30 | — | — | WO | disclosed |
| CN-114641496-A | Multispecific binding proteins for cancer therapy | 勃林格殷格翰国际有限公司 | 2022-06-17 | — | — | CN | disclosed |
| CN-114554857-A | Baked good composition comprising psicose | 玉米产品开发公司 | 2022-05-27 | — | — | CN | disclosed |
| CN-114423748-A | Novel heteroaryl triazole compounds as pesticides | 拜耳公司 | 2022-04-29 | — | — | CN | disclosed |
| CN-114213510-A | Modified Cry1Ca toxins useful for controlling insect pests | 美国陶氏益农公司 | 2022-03-22 | — | — | CN | disclosed |
| CN-114177225-A | Application of oyster and kudzu root compound traditional Chinese medicine composition in aspect of treating/preventing hyperlipidemia | 广西医科大学 | 2022-03-15 | — | — | CN | disclosed |
| WO-2022040202-A1 | B-CELL BASED IMMUNOTHERAPY FOR THE TREATMENT OF GLIOBLASTOMA AND OTHER CANCERS | NORTHWESTERN UNIVERSITY (US) | 2022-02-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250057873-A1 | Intestinal Tumor Suppressor, PGE2 Production Inhibitor, and IL-22BP Production Promoter | ILF2, PTGS1, IL36G | ESR1 4703/4885LMNA 3753/4885SMN1; SMN2 4882/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.